Calidi Biotherapeutics, Inc. (CLDI) earnings
CLDI earnings moved a median of +1.03% by the close. Quarterly and annual CLDI reports and results, each read against the price at its own news timestamp. Back to the CLDI overview →
18 measured CLDI earnings events.
Where these CLDI earnings landedvs 18 measured CLDI earnings reactions
| Middle 50% of CLDI earnings reactions | -2.57% to +6.00% |
|---|---|
| Median reaction (to close) | +1.03% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 CLDI earnings events with a measured close landed between -2.57% and +6.00%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights | Press release | +2.50% | +6.00% | |
| Form 10-Q Calidi Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.50% | +6.00% | |
| Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights | Press release | +3.56% | +16.00% | |
| Form 10-Q Calidi Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | +3.56% | +16.00% | |
| Form 10-K Calidi Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | -4.74% | -16.11% | |
| Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights | Press release | -0.59% | -0.40% | |
| Form 10-Q Calidi Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.59% | -0.40% | |
| Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights | Press release | -2.38% | -1.19% | |
| Form 10-Q Calidi Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.38% | -1.19% | |
| Form 10-K Calidi Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.66% | -5.61% | |
| Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results | Press release | +2.08% | +35.20% | |
| Form 10-Q Calidi Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.08% | +35.20% | |
| Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results | Press release | -0.61% | -3.03% | |
| Form 10-Q Calidi Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.61% | -3.03% | |
| Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results | Press release | -2.39% | +3.55% | |
| Form 10-Q Calidi Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.39% | +3.55% | |
| Form 10-K Calidi Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.07% | -5.38% | |
| Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results | Press release | +0.49% | +2.45% |
Keep exploring
More CLDI: analyst actions → · SEC filings → · CLDI overview →